Ten Years of EWAS.
Adv Sci (Weinh)
; 8(20): e2100727, 2021 10.
Article
em En
| MEDLINE
| ID: mdl-34382344
ABSTRACT
Epigenome-wide association study (EWAS) has been applied to analyze DNA methylation variation in complex diseases for a decade, and epigenome as a research target has gradually become a hot topic of current studies. The DNA methylation microarrays, next-generation, and third-generation sequencing technologies have prepared a high-quality platform for EWAS. Here, the progress of EWAS research is reviewed, its contributions to clinical applications, and mainly describe the achievements of four typical diseases. Finally, the challenges encountered by EWAS and make bold predictions for its future development are presented.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Metilação de DNA
/
Predisposição Genética para Doença
/
Epigenoma
/
Doenças Genéticas Inatas
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article